Recruiting NA Multiple Sclerosis (Relapsing Remitting)

New treatment option for Multiple Sclerosis (Relapsing Remitting)

Official title Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis

ClinicalTrials.gov ID: NCT06919900

What this study is testing

What it's testing
The primary purpose of this interventional study is to examine the overall motor learning capacity from exposure to repeated perturbations among ambulatory people with multiple sclerosis (MS). This project will advance our understanding of learning new motor skills from exposure to external perturbations.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 45 to 89

You may be able to join if

  • Clinically confirmed multiple sclerosis
  • At least 45 years old
  • Able to walk independently at least 25 feet
  • Able to stand independently for at least 30 seconds
  • Patient Determined Disability Steps score between 0 and 4

You likely can't join if

  • Previous experience with perturbation training
  • T-score from the dual x-ray absorptiometry (DXA) scan of less than -2.5
  • Coexisting psychiatric disorders or other neurological conditions, severe medical illness, or cardiovascular diseases
  • Participants have had a relapse in the past 8 weeks
See the full eligibility criteria
Who can join
  • Clinically confirmed multiple sclerosis
  • At least 45 years old
  • Able to walk independently at least 25 feet
  • Able to stand independently for at least 30 seconds
  • Patient Determined Disability Steps score between 0 and 4
  • Free from pregnancy
  • Montreal Cognitive Assessment score of 23 or higher
What rules you out
  • Previous experience with perturbation training
  • T-score from the dual x-ray absorptiometry (DXA) scan of less than -2.5
  • Coexisting psychiatric disorders or other neurological conditions, severe medical illness, or cardiovascular diseases
  • Participants have had a relapse in the past 8 weeks

The study team makes the final eligibility decision.

Where it's taking place

  • Atlanta, Georgia, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 45 years to 89 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Atlanta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.